PRESS RELEASE published on 05/15/2024 at 07:30, 2 years 4 months ago Inside Information / News release on accounts, results MaaT Pharma announces successful completion of 19.2 million euros Global Offering with new shares, aims to fund R&D activities, Phase 3 trials, and broaden pipeline Biotechnology Fundraising Clinical Trials Global Offering MaaT Pharma
BRIEF published on 05/14/2024 at 19:39, 2 years 4 months ago MaaT Pharma Announces 18 Million Euro Global Offering and Strategic Developments Financial Strategy Phase 3 Trial Clinical-stage Biotechnology Global Offering Microbiome Ecosystem Therapies
BRIEF published on 05/14/2024 at 19:39, 2 years 4 months ago MaaT Pharma annonce une offre mondiale et des développements stratégiques de 18 millions d'euros Stratégie Financière Essai De Phase 3 Offre Globale Thérapies Écosystémiques Du Microbiome Biotechnologie Au Stade Clinique
PRESS RELEASE published on 05/14/2024 at 19:34, 2 years 4 months ago Inside Information / News release on accounts, results MaaT Pharma launches a global offering of approximately 18 million euros to fund R&D activities and expand shareholder base. Current shareholders commit to significant subscriptions Global Offering MaaT Pharma 18 Million Euros R&D Activities Shareholder Commitments
PRESS RELEASE published on 05/14/2024 at 19:34, 2 years 4 months ago Informations privilégiées / Communiqué sur comptes, résultats MaaT Pharma lance une augmentation de capital de 18 millions d'euros pour financer ses activités de R&D, incluant des essais cliniques aux États-Unis et en Europe Actionnaires Augmentation De Capital R&D Essais Cliniques MaaT Pharma
Published on 10/01/2026 at 01:21, 2 hours 40 minutes ago Revival Gold Announces Filing of Final Base Shelf Prospectus
Published on 10/01/2026 at 01:00, 3 hours 1 minute ago Algo Grande Copper Secures Five-Year Surface Access Agreement With Ejido Palos Chinos at the Adelita Project
Published on 09/30/2026 at 23:30, 4 hours 31 minutes ago Early Warning News Release Issued with Respect to the Acquisition of Securities of Cypher Metaverse Inc.
Published on 09/30/2026 at 20:35, 7 hours 26 minutes ago Fairplay Ventures Inc. Enters Into Definitive Agreement to Complete Qualifying Transaction With Ampere Metals Pty. Limited
Published on 09/30/2026 at 15:50, 12 hours 11 minutes ago Innodata Opens Motion-Capture AI Lab to Help Humanoids Move Like Humans
Published on 09/30/2026 at 23:23, 4 hours 38 minutes ago LM PAY S.A. publishes audited FY 2025 results: EBIT reaches PLN 12.4 million and exceeds preliminary result and guidance
Published on 09/30/2026 at 22:34, 5 hours 27 minutes ago The Change of Date of the Annual Report 2025 Publication
Published on 09/30/2026 at 22:05, 5 hours 56 minutes ago ADS-TEC Energy Reports First Half 2026 Results; Advances Gigawatt-Scale SKM Storage Project and Strengthens its Position to Scale Own & Operate Model
Published on 09/30/2026 at 22:05, 5 hours 56 minutes ago Abivax to Present Data on Obefazimod at United European Gastroenterology (UEG) Week 2026
Published on 09/30/2026 at 22:05, 5 hours 56 minutes ago Abivax présentera des données sur l’obéfazimod lors de l’United European Gastroenterology (UEG) Week 2026
Published on 09/30/2026 at 18:44, 9 hours 16 minutes ago Broadcast of the 5th edition of “On the way up”
Published on 09/30/2026 at 18:44, 9 hours 16 minutes ago Diffusion de la 5e édition de “On the way up”
Published on 09/30/2026 at 18:18, 9 hours 43 minutes ago Nombre total de droits de vote et d'actions composant le capital social
Published on 09/30/2026 at 18:15, 9 hours 46 minutes ago The Belgian State and ENGIE Group have agreed to extend the target date for concluding the Heads of Terms until 4 november 2026
Published on 09/30/2026 at 18:15, 9 hours 46 minutes ago L’État belge et le groupe ENGIE ont convenu de reporter au 4 novembre 2026 la date cible pour la conclusion des Heads of Terms
